Differences Among Popular GLP-1 Receptor Agonists for Type 2 Diabetes
Thanks for listening to The Peptide Podcast.
A class of medications known as GLP-1 receptor agonists has revolutionized the treatment of type 2 diabetes and obesity. These drugs mimic the action of glucagon-like peptide-1 (GLP-1), a hormone that stimulates insulin secretion and inhibits glucagon release, helping to regulate blood sugar levels and promote weight loss.
In this podcast, we'll talk about the differences among some of the most well-known GLP-1 receptor agonists for type 2 diabetes.
Read the Full Episode Transcript…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.